MIAMI LAKES, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Galatea Bio, a leader in precision health, announced today the launch of StrataRisk™, a Polygenic Risk Score (PRS) Software-as-a-Service (SaaS) ...
The spread of possible SightScore results is shown as a ‘bell curve,’ with most people near the middle, and fewer people at the upper and lower risk ends. (Graphic: Business Wire) SAN DIEGO, February ...
Please provide your email address to receive an email when new articles are posted on . The saliva test evaluates a patient’s genetic variants to determine risk for glaucoma development or progression ...
Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced the U.S. launch of SightScore, the first commercially available clinical polygenic risk score testing service ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback